Trial intelligence / Profile preview

Ketamine for pain control after total knee arthroplasty

IRCT20220315054298N1Phase 3Completed

Sponsor
Tehran University of Medical Sciences
Start
Jun 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in knee osteoarthritis (OA) comparing Ketamine with Placebo (2 arms). Primary endpoints: Postoperative pain, Time to first analgesic request and 6 more. Started Jun 2022; status: completed.

02

Drugs

ketamine
03

Conditions

knee osteoarthritis (OA)

Beyond the preview

Go deeper on IRCT20220315054298N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20220315054298N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call